Table 1 Clinical and demographic characteristics of the study population
Female | Male | p | |
|---|---|---|---|
All patients, n (%) | 718 (59.4) | 491 (40.6) | |
Age, years: median (IQR) | 44 (33–58) | 48 (35–65) | 0.0002 |
MS, n (%) | 204 (68.7) | 93 (31.3) | |
Age, years: median (IQR) | 37.0 (30.0–45.0) | 35.0 (29.0–45.0) | 0.5289 |
Relapsing–remitting: n | 163 | 72 | |
Secondary progressive: n | 23 | 11 | |
Primary progressive: n | 18 | 10 | |
OIND, n (%) | 132 (47.0) | 149 (53.0) | |
Age, years: median (IQR) | 52.5 (39.0–63.6) | 52.0 (38.5–69.0) | 0.5070 |
Diagnosis (n) | Infectious diseases (17) Autoimmune neurological diseases (46) Paraneoplastic CNS neurological syndromes (4) Aseptic or bacterial meningitis; aseptic encephalitis or myelitis (16) Inflammatory demyelinating neuropathies (40). Inflammatory neuritis (9) | Infectious diseases (15) Autoimmune neurological diseases (26) Paraneoplastic CNS neurological syndromes (10) Aseptic or bacterial meningitis; aseptic encephalitis or myelitis (26) Inflammatory demyelinating neuropathies (59) Inflammatory neuritis (13) | |
NIND, n (%) | 146 (49.2) | 151 (50.8) | |
Age, years: median (IQR) | 52.0 (38.8–68.0) | 53.0 (37.0–66.0) | 0.7482 |
Diagnosis (n) | CNS expansions (14) Vascular diseases (50) Neurodegenerative diseases (20) Hereditary/metabolic encephalopathies (4) Unconsciousness (18) Non-inflammatory PNS involvement (16) CSF flow abnormalities (5) Dementia and Parkinson syndromes (19) | CNS expansions (13) Vascular diseases (51) Neurodegenerative diseases (27) Hereditary/metabolic encephalopathies (2) Unconsciousness (10) Non-inflammatory PNS involvement (27) CSF flow abnormalities (2) Dementia and Parkinson syndromes (19) | |
UNK, n (%) | 236 (70.7) | 98 (29.3) | |
Age, years: median (IQR) | 42.4 (31.0–58.0) | 51.0 (40.8–66.0) | 0.0002 |